Product
SPH 3348
1 clinical trial
1 indication
Indication
Solid TumorClinical trial
Phase I Clinical Study of SPH3348 Tablets, a c-Met Inhibitor, in Patients With Advanced Solid Tumors With c-Met AbnormalitiesStatus: Recruiting, Estimated PCD: 2024-03-30